# Safflomide

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/safflomide
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Safflomide, Carthamus tinctorius bioactive compound, Safflower adiponectin activator, Honghua compound, Carthamus extract metabolite, TCM safflower derivative

## Overview

Safflomide is a phenylpropanoid amide compound isolated from safflower (Carthamus tinctorius) seeds, structurally related to [serotonin](/ingredients/condition/mood)-conjugated hydroxycinnamic acid derivatives. Its primary mechanism involves upregulating adiponectin secretion from adipose tissue, which activates downstream AMPK and PPARα signaling pathways to support metabolic homeostasis.

## Health Benefits

• Increases plasma adiponectin levels by over 30% in high-fat diet models (preliminary animal evidence)
• May support metabolic health through adiponectin pathway activation (preliminary evidence)
• Related safflower extracts show benefits for abdominal obesity and [insulin resistance](/ingredients/condition/weight-management) (moderate human evidence, PMID: 34487844)
• Parent plant compounds demonstrate [neuroprotective effect](/ingredients/condition/cognitive)s in Parkinson's disease models (preliminary animal evidence)
• Traditional use suggests [cardiovascular](/ingredients/condition/heart-health) and [anti-inflammatory](/ingredients/condition/inflammation) support (traditional evidence only)

## Mechanism of Action

Safflomide appears to stimulate adiponectin gene expression and secretion in adipocytes, with adiponectin subsequently binding AdipoR1 and AdipoR2 receptors to activate AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPARα). AMPK activation promotes fatty acid oxidation and inhibits lipogenic enzyme activity, including acetyl-CoA carboxylase (ACC), thereby reducing ectopic lipid accumulation. Additionally, PPARα upregulation enhances [mitochondrial](/ingredients/condition/energy) beta-oxidation and modulates [inflammatory](/ingredients/condition/inflammation) cytokine expression, contributing to improved [insulin sensitivity](/ingredients/condition/weight-management) at the cellular level.

## Clinical Summary

Preclinical evidence from high-fat diet-induced rodent models demonstrates that safflomide administration increases plasma adiponectin concentrations by more than 30% compared to controls, alongside improvements in lipid profiles and glycemic markers. These findings are preliminary and derive exclusively from animal studies; no peer-reviewed randomized controlled trials in human subjects have been published specifically for isolated safflomide as of current literature. Broader research on standardized safflower extract preparations containing related phenylpropanoid amides has shown modest benefits for abdominal obesity and [insulin resistance](/ingredients/condition/weight-management) in human trials, providing indirect supportive context. Overall, the evidence base is early-stage and insufficient to establish clinical dosing recommendations or confirm efficacy in human populations.

## Nutritional Profile

Safflomide is a synthetic amide derivative compound, not a whole food ingredient, and therefore does not possess a conventional macronutrient or micronutrient profile. It is characterized as a bioactive small molecule rather than a nutritional source. Key bioactive identity: Safflomide is structurally related to [serotonin](/ingredients/condition/mood) amide derivatives found in safflower (Carthamus tinctorius) seeds, particularly analogous to serotonin hydroxycinnamic acid amides (e.g., N-feruloylserotonin, N-(p-coumaroyl)serotonin) which occur in safflower at concentrations of approximately 0.1–1.5 mg/g dry seed weight. As a compound-category ingredient, it contains no appreciable macronutrients (protein, fat, carbohydrates), dietary fiber, or conventional micronutrients (vitamins, minerals). Bioactive concentration in formulations: typically dosed in microgram-to-milligram ranges consistent with pharmacological rather than nutritional use. Bioavailability notes: Parent safflower serotonin amide compounds demonstrate moderate oral bioavailability with lipophilic characteristics aiding membrane permeability; specific bioavailability data for Safflomide itself remains limited to preliminary animal pharmacokinetic models. The compound's primary relevance is its ability to modulate adiponectin secretion pathways (PPAR-gamma and AMPK-related signaling), placing it in the category of a bioactive modulator rather than a nutrient. No caloric contribution, vitamin content, or mineral content is applicable.

## Dosage & Preparation

No clinically studied human dosages exist for safflomide. Preclinical studies used 3 mg/day orally in rats. Related safflower extracts have been studied at 25-100 mg/kg/day in animals and 8 g/day safflower oil in humans. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safflomide lacks dedicated human safety and toxicology trials, making a comprehensive adverse effect profile impossible to establish at this time. Because safflomide is derived from Carthamus tinctorius, individuals with known allergies to Asteraceae/Compositae family plants should exercise caution due to potential cross-reactivity. Theoretically, its adiponectin-enhancing and AMPK-activating properties could have additive effects when combined with antidiabetic medications such as metformin or insulin, potentially increasing hypoglycemia risk, though this interaction has not been formally studied. Pregnant and breastfeeding individuals should avoid safflomide-containing supplements due to the complete absence of safety data in these populations.

## Scientific Research

Human clinical evidence for safflomide itself is absent, with research limited to one preclinical rat study (PMID: 22428927) showing 3 mg/day increased adiponectin levels. Related safflower oil showed benefits in a 2022 RCT (PMID: 34487844, n=67) where 8 g/day for 12 weeks improved metabolic syndrome parameters.

## Historical & Cultural Context

Safflower has been used in traditional Chinese medicine since at least 1978 for [cardiovascular](/ingredients/condition/heart-health) diseases, diabetes, and circulation issues. In Persian traditional medicine, it treats conditions ranging from [inflammation](/ingredients/condition/inflammation) and rheumatism to melancholy and poisoning.

## Synergistic Combinations

Berberine, Chromium, Alpha-lipoic acid, Green tea extract, Cinnamon extract

## Frequently Asked Questions

### What is safflomide and what plant is it derived from?

Safflomide is a phenylpropanoid amide phytochemical extracted from the seeds of Carthamus tinctorius, commonly known as safflower. It belongs to a class of bioactive compounds that include hydroxycinnamic acid amides conjugated with biogenic amines, structurally analogous to serotonin-derived alkaloids found in other oilseed plants.

### How much does safflomide increase adiponectin levels?

In high-fat diet rodent model studies, safflomide has been shown to increase plasma adiponectin concentrations by over 30% relative to untreated controls. Adiponectin is an anti-inflammatory adipokine that declines in obesity and insulin resistance, so this elevation is considered metabolically significant, though these results have not yet been replicated in human clinical trials.

### What is the difference between safflomide and standard safflower extract?

Standard safflower extract is a broad-spectrum preparation containing multiple bioactives including flavonoids like carthamin and hydroxysafflor yellow A, as well as various phenylpropanoid amides including safflomide. Safflomide refers specifically to one isolated phenylpropanoid amide compound within that complex, meaning whole safflower extract research cannot be directly attributed to safflomide alone, though it provides relevant mechanistic context.

### Can safflomide help with insulin resistance?

Animal model data suggest safflomide may improve insulin sensitivity indirectly by raising adiponectin levels, which activates AMPK and PPARα pathways that enhance glucose uptake and fatty acid oxidation in skeletal muscle and liver tissue. However, no human clinical trials have tested safflomide specifically for insulin resistance outcomes, so its efficacy in this context remains unconfirmed and speculative based on current evidence.

### Is safflomide safe to take with metformin or other diabetes medications?

No specific drug interaction studies have been conducted for safflomide combined with metformin or other antidiabetic agents. Because safflomide activates AMPK pathways similarly to metformin and may enhance insulin sensitivity through adiponectin upregulation, there is a theoretical risk of additive blood glucose-lowering effects and hypoglycemia when combined. Anyone taking glucose-lowering medications should consult a healthcare provider before using safflomide-containing supplements.

### What does current research show about safflomide's effectiveness compared to placebo?

Most evidence for safflomide comes from animal studies showing over 30% increases in adiponectin levels on high-fat diets, which is promising but preliminary. Related safflower extracts have demonstrated moderate efficacy in human trials for abdominal obesity and insulin resistance (PMID: 34487844), though safflomide-specific human clinical data remains limited. More rigorous human studies are needed to confirm whether safflomide delivers the metabolic benefits observed in animal models.

### Who would benefit most from taking safflomide supplementation?

Safflomide may be most relevant for individuals with metabolic concerns related to low adiponectin levels, such as those struggling with insulin resistance or metabolic syndrome, based on its proposed mechanism of action. Those interested in neuroprotective support may also consider safflomide given preliminary evidence that parent safflower compounds show protective effects in neurological models. However, anyone considering safflomide should consult a healthcare provider, as human safety and efficacy data remain limited.

### What affects how well safflomide is absorbed and used by the body?

Bioavailability data specific to safflomide is not well-established in published research, though absorption of safflower compounds may be influenced by dietary fat content and individual gastrointestinal health. The exact formulation and extraction method used to produce safflomide may impact its bioavailability, similar to other plant-derived bioactives. Taking safflomide with meals containing fat may theoretically enhance absorption, but this has not been formally studied for this ingredient.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*